Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
05/11/2024 | 21:33 | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:CMXC | Cell MedX Corporation (PK) |
15/10/2024 | 18:54 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:CMXC | Cell MedX Corporation (PK) |
29/08/2024 | 20:57 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | USOTC:CMXC | Cell MedX Corporation (PK) |
06/03/2024 | 22:49 | Edgar (US Regulatory) | Form DEF 14C - Other definitive information statements | USOTC:CMXC | Cell MedX Corporation (PK) |
22/02/2024 | 22:38 | Edgar (US Regulatory) | Form PRE 14C - Other preliminary information statements | USOTC:CMXC | Cell MedX Corporation (PK) |
22/02/2024 | 18:48 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | USOTC:CMXC | Cell MedX Corporation (PK) |
10/01/2024 | 00:08 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:CMXC | Cell MedX Corporation (PK) |
09/01/2024 | 21:29 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | USOTC:CMXC | Cell MedX Corporation (PK) |
07/09/2023 | 23:00 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial ownership | USOTC:CMXC | Cell MedX Corporation (PK) |
29/08/2023 | 23:20 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | USOTC:CMXC | Cell MedX Corporation (PK) |
19/05/2023 | 19:49 | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:CMXC | Cell MedX Corporation (PK) |
07/04/2023 | 21:04 | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:CMXC | Cell MedX Corporation (PK) |
18/10/2022 | 23:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:CMXC | Cell MedX Corporation (PK) |
29/08/2022 | 22:11 | Edgar (US Regulatory) | Notification That Annual Report Will Be Submitted Late (nt 10-k) | USOTC:CMXC | Cell MedX Corporation (PK) |
18/05/2022 | 18:40 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | USOTC:CMXC | Cell MedX Corporation (PK) |
09/04/2022 | 01:43 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:CMXC | Cell MedX Corporation (PK) |
14/10/2021 | 17:04 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | USOTC:CMXC | Cell MedX Corporation (PK) |
15/06/2021 | 14:30 | InvestorsHub NewsWire | BIG MEDICAL COMPANIES ARE INVESTING IN ELECTROCEUTICALS - A BREAKTHROUGH IN THERAPEUTICS | USOTC:CMXC | Cell MedX Corporation (PK) |
15/03/2021 | 11:29 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | USOTC:CMXC | Cell MedX Corporation (PK) |
04/03/2021 | 19:35 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | USOTC:CMXC | Cell MedX Corporation (PK) |
06/05/2020 | 12:08 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | USOTC:CMXC | Cell MedX Corporation (PK) |
29/04/2020 | 22:10 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | USOTC:CMXC | Cell MedX Corporation (PK) |
16/04/2019 | 12:04 | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late (nt 10-q) | USOTC:CMXC | Cell MedX Corporation (PK) |
16/10/2018 | 12:04 | Edgar (US Regulatory) | Amended Quarterly Report (10-q/a) | USOTC:CMXC | Cell MedX Corporation (PK) |
08/05/2017 | 16:21 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | USOTC:CMXC | Cell MedX Corporation (PK) |
03/02/2017 | 19:41 | Edgar (US Regulatory) | Report of Proposed Sale of Securities (144) | USOTC:CMXC | Cell MedX Corporation (PK) |
25/04/2016 | 12:07 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | USOTC:CMXC | Cell MedX Corporation (PK) |
08/12/2014 | 22:59 | Edgar (US Regulatory) | Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1) | USOTC:CMXC | Cell MedX Corporation (PK) |
17/07/2014 | 23:23 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | USOTC:CMXC | Cell MedX Corporation (PK) |
25/03/2014 | 17:08 | Marketwired | Sports Asylum, Inc., fka Plandel Resources, Inc., Announces the Company's Focus on the Socialization of the Recreational Spor... | USOTC:CMXC | Cell MedX Corporation (PK) |